ArticleThe oncologist2020

Sorafenib for Patients with Hepatocellular Carcinoma and Child-Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study.

Tim A Labeur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.